Spray Cryotherapy for the Management of Benign Central Airway Stenosis (Cryo-BAS)
NCT ID: NCT06761170
Last Updated: 2025-07-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE2
50 participants
INTERVENTIONAL
2025-06-02
2027-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. What is the need for reintervention and time to reintervention in participants with benign airway stenosis with simple stenosis who receive spray cryotherapy plus balloon dilatation versus standard of care alone?
2. To evaluate patient experience, physiological, anatomical changes, health care utilization and safety of the SCT plus balloon dilatation versus standard of care alone.
Researchers will compare spray cryotherapy plus balloon dilatation versus current standard of Care (SoC - steroid injection, radial cuts and balloon dilatation) in patients with benign airway stenosis with simple stenosis to see if it reduces the need of re intervention.
Participants will surgery and receive one of the two interventions.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cryospray Therapy Versus Standard of Care for Benign Airway Stenosis (CryoStasis)
NCT04996173
Non-Invasive Neurostimulation of the Vagus Nerve With the AlphaCore Device for the Relief of EIB
NCT01923272
Tracheobronchomalacia: Treatment Outcomes
NCT00550602
Evaluation of the Safety and Tolerability of Nitric Oxide (NO) Via Inhalation to Subjects With Bronchiolitis
NCT01768884
Mucociliary Clearance Techniques in Moderate Bronchiolitis
NCT04553822
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study will span 2-year duration with 1 year recruitment. Follow up at 6 weeks, 3 months, 6 months, 12 months. The patient's airway will be either a laryngeal mask airway or a rigid bronchoscopy for passive venting and gas egress.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Interventional
1. Stenotic lumen diameter \> 8mm:
1. Spray Cryo Therapy for 5s, repeated 3-5 cycles
2. Balloon dilation (to normal airway diameter)
2. Stenotic lumen diameter \< 8mm
1. Balloon dilation (up to 8mm diameter)
2. Spray Cryo Therapy for 5s, repeated 3-5 cycles 3) Balloon dilation (to normal airway diameter)
Spray cryo therapy
normal flow, 5 seconds repeated for 3-5 cycles
Control
1. Steroid injection
2. Radial mucosal incision
3. Balloon dilation (to normal airway diameter)
Standard of Care (SOC)
1. Steroid injection
2. Radial mucosal incision
3. Balloon dilation (to normal airway diameter)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Spray cryo therapy
normal flow, 5 seconds repeated for 3-5 cycles
Standard of Care (SOC)
1. Steroid injection
2. Radial mucosal incision
3. Balloon dilation (to normal airway diameter)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2\. Stenotic airway of diameter \< 1cm.
Exclusion Criteria
2. Patients with giant bullae (\> a third of hemithorax) or bullae \>3cm.
3. Concurrent tracheoesophageal fistula, active tracheal malignancy.
4. Presence of concomitant upper airway obstruction.
5. Pregnancy
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Association of Broncology and Interventional Pulmonology
UNKNOWN
Beth Israel Deaconess Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Adnan Majid, MD
Chief, Section of Interventional Pulmonology, Division of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, Professor of Medicine, Harvard Medical School,
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Leong P, Bardin PG, Lau KK. What's in a name? Expiratory tracheal narrowing in adults explained. Clin Radiol. 2013 Dec;68(12):1268-75. doi: 10.1016/j.crad.2013.06.017. Epub 2013 Aug 13.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024P000875
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.